TECHNICAL ISSUES IN BREAST
RADIOTHERAPY
Dr Bharti Devnani
Moderator:- Dr Manoj Kumar Sharma
RADIOTHERAPY BY CONVENTIONAL
METHOD
IMMOBILIZATION METHODS FOR
IMPLEMENTATION
BREAST BOARD
 Several adjustable features to allow for the manipulation of
patients arms, wrists, head and shoulders.
 To make chest wall surface horizontal, brings arms out of the way
of lateral beams.
 Arm abducted at 90⁰ & hand holds handle of arm rest.
 Face turned towards opposite side.
 Thermoplastic breast support can be added.
 Constructed of carbon fiber which has lower attenuation levels
permitting maximum beam penetration.
VAC-LOCK
Breast ring with
valecro Alpha cradle
FIELD BORDERS
FOR TANGENTIAL FIELDS
 Upper border – 2nd ICS (angle of Louis) when supra
clavicular field used.
When SCF not irradiated – head of clavicle
 Medial border – at or 1cm away from midline
 Lateral border – 2-3cm beyond all palpable breast
tissue – mid axillary line
 Lower border – 2cm below inframammary fold
 Anterior -2cm margin of light, above the highest point of
breast.
 A pectoralis major
muscle
 B axillary lymph
nodes: levels I
 C axillary lymph
nodes: levels II
 D axillary lymph
nodes: levels III
 E supraclavicular
lymph nodes
 F internal
mammary lymph
nodes
HOW TO IMPLEMENT IT?
Deciding angle of rotation of gantry for tangential
fields:
 Lead wire placed on lateral border
 Field opened at 0⁰ rotation on chest wall and
central axis placed along medial border of marked
field
 Gantry rotated , until on fluoroscopy, central axis &
lead wire intersect – angle of gantry at that pt.
noted – medial tangent angle
CENTRAL LUNG DISTANCE
 Perpendicular distance from post. tangential field
edge to post part of ant. chest wall at centre of field
 Best predictor of %age of ipsilateral lung vol.
treated by tangential fields
CLD (cm) % of lung
irradiated
1.5 cm 6%
2.5 cm 16%
3.5 cm 26%
IMPORTANCE OF BEAM MODIFICATION
DEVICES (WEDGES)
Higher dose to
the apex without
wedges
BOLUS
 Increases dose to skin & scar after mastectomy
 Cosmetic results may be inferior
 Universal wax bolus used
IRRADIATION OF REGIONAL
LYMPHATICS
SCF IRRADIATION
SCF
 Single anterior field is used.
Field borders –
 Upper border : thyrocricoid groove
 Medial border : at or 1cm across midline extending
upward following medial border of SCM ms to
thyrocricoid groove
 Lateral border: insertion of deltoid muscle
 Lower border : matched with upper order of
tangential fields
 A pectoralis major
muscle
 B axillary lymph
nodes: levels I
 C axillary lymph
nodes: levels II
 D axillary lymph
nodes: levels III
 E supraclavicular
lymph nodes
 F internal
mammary lymph
nodes
SUPRACLAVICULAR-AXILLARY FIELD
Humeral head shielding:–
• If arm angled >90⁰: Ax nodes overlap head of
humerus anteriorly.
• Larger the angle – less the head of humerus
spared in s.c port
MATCHING SUPRACLAV & CHEST WALL
FIELDS
Angulation
By inferior angulation of the
tangential fields.
Half beam block technique
Blocking the supraclav field’s
inferior half, eliminating its
divergence inferiorly .
Hanging block technique
Superior edge of tangential beam
made vertical by vertical
hanging block.
Single isocentre technique:
• Isocentre placed at the junction
of tangential and supraclavicular
field
• Inferior portion of field blocked for
supraclavicular treatment and
superior portion blocked for
tangential field
IMN IRRADIATION
1. Extension of tangential fields– by extending medial
border – 3cm across midline or by using imaging
techniques
2. Separate field –
• Medial border – midline , matching with tangential
field border
• Lateral border – 5-6cm from midline
• Superior border – abuts inferior border of supraclav
field or at 1st ICS (superior border of head of clavicle)
if only IMNs are to be treated
• Inferior border – at xiphoid or higher if 1st three ICS
covered
More normal tissue is being irradaited. (lung, heart and
contralateral breast)
Anterior field Oblique field
MATCHING THE TANGENTIAL BEAMS
WITH INTERNAL MAMMARY FIELD
ISSUES WITH DIRECT ANTERIOR FIELD (LARGE
BREASTED WOMEN)
Cold region:- large
amount of breast tissue
over the matchline
POSTERIOR AXILLARY BOOST
 Medial border – To allow
1.5-2cm of lung on the
portal film
 Inferior border –
at same level of inferior
border of s.c field
 Lateral border – just blocks
fall off across post axillary fold
 Superior border – splits the clavicle
 Superolaterally – shields or splits humeral head
 Centre – at acromial process of scapula
ELECTRON BOOST
BOOST-ELECTRONS
 Appropriate energy selected to allow 85 -90%
isodose line to encompass target volume &
decrease dose to the lung.
 Clinical set up - post lumpectomy volume or scar
on skin +3 cm in all directions.
 Energy – 9-16 MeV
 Dose – 10-20Gy
TREATMENT IN PRONE POSITION
Plexiglas plateform
with rounded
opening
TREATMENT IN LATERAL DECUBITUS
POSITION
Carbon epoxy
disposer
Opposite breast
retracted upwards &
outwards from the field
by elastic straps
•Useful for voluminous breast
•For patients who are heavy smoker and previous
history of lung or cardiac disease
•For deep seated tumor
Disadvantage – For nodal RT treatment position
has to be changed
TREATMENT OF BILATERAL BREAST
CANCER WITH CONVENTIONAL
TECHNIQUE
ROLE OF IMRT IN BREAST CANCER
 Reduces the hotspots specially in the superior and
inframammary portions of the breast.
Increases homogenity
Manifests clinically into decrease in moist
desqumation in these areas.
IMRT BREAST: WHY?
(1) Better dose homogeneity for whole breast RT
(2) Better coverage of tumor cavity
(3) Feasibility of SIB
(4) Decrease dose to the critical organs
(5) Left sided tumors- decrease heart dose
FORWARD PLAN IMRT
ROLE OF 4D-CRT
RTOG GUIDELINES
DURING CT SIMULATION
Post-BCS
Post-Mastectomy
REGIONAL NODAL CONTOURING
Breast-superior
Breast-inferior
SCF begins
Axillary level III begins
Axillary level II begins
Axillary level I begins
Axillary level I ends
IMC begins
IMC ends
THANK YOU
INTERSTICIAL BOOST
When the CTV extends deeper
than 28 mm under the epidermal
surface, implants have a higher
ballistic selectivity in terms of the
volume of the irradiated breast
tissue and dose to the skin blood
vessels than electron beam
boosts.
LOCALIZATION OF LUMPECTOMY CAVITY
 Pre-op clinical finding , pictures
 Imaging- mammogram,usg,MRI
 Per-op finding
 HPR
 Surgical clips
 Post op imaging with USG,CT or MRI
Use of marker clips to
localise the boost
target volume and
simulate entrance
points of guide needle
at the skin of the breast
Use of mammography in defining
the boost target localisation in
breast conserving treatment
A. Defining the implantation isocentre and definitive needle entrance
and exit points at the skin for a breast implant. Reconstruction boost
target isocentre from mammography, by simulator, or CT. The
indicated entrance points are too close to the target volume (A)
B. Inclination of the implantation equator plane away from the target to
avoid an overlap of the boost PTV and needle exit points at the skin
(C). Indication of new entrance and exit points, further away from
the boost CTV, to avoid skin teleangiectases .
(D)Occurrence of severe teleangiectasic ‘stars’ at skin entrance or
exit points if rules for implementation are not followed
Why this planning so important.
With a delivered dose of 50 Gy , chances of late teleangiectases
may occur in 30% of cases
Vessels may have already received 20–40 Gy from the breast
irradiation.Therefore, there is usually only a small dose amount left
in skin vessel tolerance for teleangiectases
ANAESTHESIA
 Breast implants can easily be carried out under L.A. and
premedication with 2.5–5 mg midazolam given 15–30
min before the implantation.(GA, <0.5%)
 The patient is placed in supine position with the
homolateral arm in 90° abduction.
 After the design of implant geometry and localisation of
entrance and exit points of the needles, the skin is
infiltrated at each point with 0.5–1 ml 1% lidocaine.
 Retroareolar region is painful (1-5 ml extra infiltrate in
that area)
DESIGN OF THE IMPLANT GEOMETRY
 Needles are implanted parallel and equidistance from
each other (Paris system).
 In most cases inserted in a mediolateral direction.
 In very medially or laterally located tumor sites, needles
should be implanted in a craniocaudal direction .to
enable separate target area from skin points.
 In some rare cases, the upper outer quadrant has to be
implanted with needles orientated in a 45° angle to
avoid overlap of source positions and skin
 2 planes of needles are usually needed to cover the
PTV.
 A single plane may be sufficient in case of a target
thickness of less than 12 mm.
 Three planes are required in a large breast where
the targeted breast tissue between pectoral fascia
and skin is thicker than 30 mm.
 Five to nine needles spaced 15–20 mm are usually
required.
 Reference needle is first implanted at the posterior
(deepest) side into the centre of the PTV.
 For definitive positioning, the needle should pass about
5 mm behind the internal scar.
 The other needles of the posterior plane are then
implanted parallel to the first one.
 For definitive positioning, the needle should pass about
5 mm behind the internal scar.
 The other needles of the posterior plane are then
implanted parallel to the first one.

Technical issues in breast radiotherapy

  • 1.
    TECHNICAL ISSUES INBREAST RADIOTHERAPY Dr Bharti Devnani Moderator:- Dr Manoj Kumar Sharma
  • 2.
  • 3.
  • 4.
  • 6.
     Several adjustablefeatures to allow for the manipulation of patients arms, wrists, head and shoulders.  To make chest wall surface horizontal, brings arms out of the way of lateral beams.  Arm abducted at 90⁰ & hand holds handle of arm rest.  Face turned towards opposite side.  Thermoplastic breast support can be added.  Constructed of carbon fiber which has lower attenuation levels permitting maximum beam penetration.
  • 7.
  • 8.
  • 9.
  • 10.
    FOR TANGENTIAL FIELDS Upper border – 2nd ICS (angle of Louis) when supra clavicular field used. When SCF not irradiated – head of clavicle  Medial border – at or 1cm away from midline  Lateral border – 2-3cm beyond all palpable breast tissue – mid axillary line  Lower border – 2cm below inframammary fold  Anterior -2cm margin of light, above the highest point of breast.
  • 11.
     A pectoralismajor muscle  B axillary lymph nodes: levels I  C axillary lymph nodes: levels II  D axillary lymph nodes: levels III  E supraclavicular lymph nodes  F internal mammary lymph nodes
  • 13.
    HOW TO IMPLEMENTIT? Deciding angle of rotation of gantry for tangential fields:  Lead wire placed on lateral border  Field opened at 0⁰ rotation on chest wall and central axis placed along medial border of marked field  Gantry rotated , until on fluoroscopy, central axis & lead wire intersect – angle of gantry at that pt. noted – medial tangent angle
  • 14.
    CENTRAL LUNG DISTANCE Perpendicular distance from post. tangential field edge to post part of ant. chest wall at centre of field  Best predictor of %age of ipsilateral lung vol. treated by tangential fields CLD (cm) % of lung irradiated 1.5 cm 6% 2.5 cm 16% 3.5 cm 26%
  • 15.
    IMPORTANCE OF BEAMMODIFICATION DEVICES (WEDGES)
  • 16.
    Higher dose to theapex without wedges
  • 17.
    BOLUS  Increases doseto skin & scar after mastectomy  Cosmetic results may be inferior  Universal wax bolus used
  • 18.
  • 19.
  • 20.
    SCF  Single anteriorfield is used. Field borders –  Upper border : thyrocricoid groove  Medial border : at or 1cm across midline extending upward following medial border of SCM ms to thyrocricoid groove  Lateral border: insertion of deltoid muscle  Lower border : matched with upper order of tangential fields
  • 21.
     A pectoralismajor muscle  B axillary lymph nodes: levels I  C axillary lymph nodes: levels II  D axillary lymph nodes: levels III  E supraclavicular lymph nodes  F internal mammary lymph nodes SUPRACLAVICULAR-AXILLARY FIELD
  • 22.
    Humeral head shielding:– •If arm angled >90⁰: Ax nodes overlap head of humerus anteriorly. • Larger the angle – less the head of humerus spared in s.c port
  • 23.
    MATCHING SUPRACLAV &CHEST WALL FIELDS
  • 24.
    Angulation By inferior angulationof the tangential fields. Half beam block technique Blocking the supraclav field’s inferior half, eliminating its divergence inferiorly . Hanging block technique Superior edge of tangential beam made vertical by vertical hanging block.
  • 25.
    Single isocentre technique: •Isocentre placed at the junction of tangential and supraclavicular field • Inferior portion of field blocked for supraclavicular treatment and superior portion blocked for tangential field
  • 26.
  • 27.
    1. Extension oftangential fields– by extending medial border – 3cm across midline or by using imaging techniques 2. Separate field – • Medial border – midline , matching with tangential field border • Lateral border – 5-6cm from midline • Superior border – abuts inferior border of supraclav field or at 1st ICS (superior border of head of clavicle) if only IMNs are to be treated • Inferior border – at xiphoid or higher if 1st three ICS covered
  • 28.
    More normal tissueis being irradaited. (lung, heart and contralateral breast)
  • 29.
  • 30.
    MATCHING THE TANGENTIALBEAMS WITH INTERNAL MAMMARY FIELD
  • 31.
    ISSUES WITH DIRECTANTERIOR FIELD (LARGE BREASTED WOMEN) Cold region:- large amount of breast tissue over the matchline
  • 32.
  • 33.
     Medial border– To allow 1.5-2cm of lung on the portal film  Inferior border – at same level of inferior border of s.c field  Lateral border – just blocks fall off across post axillary fold  Superior border – splits the clavicle  Superolaterally – shields or splits humeral head  Centre – at acromial process of scapula
  • 34.
  • 35.
    BOOST-ELECTRONS  Appropriate energyselected to allow 85 -90% isodose line to encompass target volume & decrease dose to the lung.  Clinical set up - post lumpectomy volume or scar on skin +3 cm in all directions.  Energy – 9-16 MeV  Dose – 10-20Gy
  • 36.
  • 37.
  • 38.
    TREATMENT IN LATERALDECUBITUS POSITION
  • 39.
    Carbon epoxy disposer Opposite breast retractedupwards & outwards from the field by elastic straps
  • 40.
    •Useful for voluminousbreast •For patients who are heavy smoker and previous history of lung or cardiac disease •For deep seated tumor Disadvantage – For nodal RT treatment position has to be changed
  • 41.
    TREATMENT OF BILATERALBREAST CANCER WITH CONVENTIONAL TECHNIQUE
  • 44.
    ROLE OF IMRTIN BREAST CANCER
  • 45.
     Reduces thehotspots specially in the superior and inframammary portions of the breast. Increases homogenity Manifests clinically into decrease in moist desqumation in these areas.
  • 47.
    IMRT BREAST: WHY? (1)Better dose homogeneity for whole breast RT (2) Better coverage of tumor cavity (3) Feasibility of SIB (4) Decrease dose to the critical organs (5) Left sided tumors- decrease heart dose
  • 48.
  • 49.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
    When the CTVextends deeper than 28 mm under the epidermal surface, implants have a higher ballistic selectivity in terms of the volume of the irradiated breast tissue and dose to the skin blood vessels than electron beam boosts.
  • 65.
    LOCALIZATION OF LUMPECTOMYCAVITY  Pre-op clinical finding , pictures  Imaging- mammogram,usg,MRI  Per-op finding  HPR  Surgical clips  Post op imaging with USG,CT or MRI
  • 66.
    Use of markerclips to localise the boost target volume and simulate entrance points of guide needle at the skin of the breast
  • 67.
    Use of mammographyin defining the boost target localisation in breast conserving treatment
  • 68.
    A. Defining theimplantation isocentre and definitive needle entrance and exit points at the skin for a breast implant. Reconstruction boost target isocentre from mammography, by simulator, or CT. The indicated entrance points are too close to the target volume (A) B. Inclination of the implantation equator plane away from the target to avoid an overlap of the boost PTV and needle exit points at the skin
  • 69.
    (C). Indication ofnew entrance and exit points, further away from the boost CTV, to avoid skin teleangiectases . (D)Occurrence of severe teleangiectasic ‘stars’ at skin entrance or exit points if rules for implementation are not followed Why this planning so important. With a delivered dose of 50 Gy , chances of late teleangiectases may occur in 30% of cases Vessels may have already received 20–40 Gy from the breast irradiation.Therefore, there is usually only a small dose amount left in skin vessel tolerance for teleangiectases
  • 70.
    ANAESTHESIA  Breast implantscan easily be carried out under L.A. and premedication with 2.5–5 mg midazolam given 15–30 min before the implantation.(GA, <0.5%)  The patient is placed in supine position with the homolateral arm in 90° abduction.  After the design of implant geometry and localisation of entrance and exit points of the needles, the skin is infiltrated at each point with 0.5–1 ml 1% lidocaine.  Retroareolar region is painful (1-5 ml extra infiltrate in that area)
  • 71.
    DESIGN OF THEIMPLANT GEOMETRY  Needles are implanted parallel and equidistance from each other (Paris system).  In most cases inserted in a mediolateral direction.  In very medially or laterally located tumor sites, needles should be implanted in a craniocaudal direction .to enable separate target area from skin points.  In some rare cases, the upper outer quadrant has to be implanted with needles orientated in a 45° angle to avoid overlap of source positions and skin
  • 73.
     2 planesof needles are usually needed to cover the PTV.  A single plane may be sufficient in case of a target thickness of less than 12 mm.  Three planes are required in a large breast where the targeted breast tissue between pectoral fascia and skin is thicker than 30 mm.  Five to nine needles spaced 15–20 mm are usually required.
  • 74.
     Reference needleis first implanted at the posterior (deepest) side into the centre of the PTV.  For definitive positioning, the needle should pass about 5 mm behind the internal scar.  The other needles of the posterior plane are then implanted parallel to the first one.  For definitive positioning, the needle should pass about 5 mm behind the internal scar.  The other needles of the posterior plane are then implanted parallel to the first one.